These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17034300)

  • 41. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers.
    Feddah MR; Davies NM
    J Pharm Pharmacol; 2003 Aug; 55(8):1055-61. PubMed ID: 12956894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.
    Nikander K; Turpeinen M; Wollmer P
    J Aerosol Med; 1999; 12(2):47-53. PubMed ID: 10539706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
    Raula J; Rahikkala A; Halkola T; Pessi J; Peltonen L; Hirvonen J; Järvinen K; Laaksonen T; Kauppinen EI
    Int J Pharm; 2013 Jan; 441(1-2):248-54. PubMed ID: 23200957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects.
    Newman SP; Newhouse MT
    J Aerosol Med; 1996; 9(1):55-70. PubMed ID: 10160209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aerosol: A Novel Vehicle for Pharmacotherapy in Neonates.
    MacLoughlin R; Telfer C; Clark A; Fink J
    Curr Pharm Des; 2017; 23(38):5928-5934. PubMed ID: 28925894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Ribavirin Aerosol With Small Particle Aerosol Generator and Vibrating Mesh Micropump Aerosol Technologies.
    Walsh BK; Betit P; Fink JB; Pereira LM; Arnold J
    Respir Care; 2016 May; 61(5):577-85. PubMed ID: 26932383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method of characterizing medicinal drug aerosols generated from pulmonary drug delivery devices.
    Ali M
    PDA J Pharm Sci Technol; 2010; 64(4):364-72. PubMed ID: 21502037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies.
    Velasquez DJ; Gabrio B
    J Aerosol Med; 1998; 11 Suppl 1():S23-8. PubMed ID: 10180729
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.
    Sommerville ML; Hickey AJ
    AAPS PharmSciTech; 2003 Nov; 4(4):E58. PubMed ID: 15198553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hollow porous particles in metered dose inhalers.
    Dellamary LA; Tarara TE; Smith DJ; Woelk CH; Adractas A; Costello ML; Gill H; Weers JG
    Pharm Res; 2000 Feb; 17(2):168-74. PubMed ID: 10751031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols.
    Alexander BD; Winkler TP; Shi S; Dodds Ashley ES; Hickey AJ
    Pharm Dev Technol; 2011; 16(6):577-82. PubMed ID: 21699390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
    Hein S; Bur M; Schaefer UF; Lehr CM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO; Corrigan OI; Healy AM
    Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.